Guideline on the Use of Ipecac Syrup in the Out-of-Hospital Management of Ingested Poisons

References

• Jukes E. New means of extracting opium etc. from the stomach. Lond Med Phys J 1822; 48:384–389.
   PubMedGoogle Scholar
• Bush F. On the common syringe with a flexible tube, as applicable to theremoval of opium and other poisons from the stomach. Lond Med Phys J 1822; 48:218–220.
   PubMedGoogle Scholar
• White W. Materia Medica, Pharmacy, Pharmacology and Therapeutics. London: J & A Churchill, 1892.
   Google Scholar
• Arnold F, Hodges J, Barta R, Spector S, Sunshine I, Wedgwood R. Evaluation of the efficacy of lavage and induced emesis in treatment of salicylate poisoning. Pediatrics 1959; 23:286–301.
   PubMed Web of Science ®Google Scholar
• Boxer L, Anderson F P, Rowe D S. Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J Pediatr 1969; 74(5):800–803.
   PubMed Web of Science ®Google Scholar
• Robertson W O. Syrup of ipecac. A fast or slow emetic? Am J Dis Child 1962; 103:136–139.
   PubMedGoogle Scholar
• Howland M A. Syrup of ipecac. In: Goldfrank L R, Howland M A, Flomenbaum N E, Hoffman R S, Lewin L S, Nelson L S, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill, 2002:465–468.
   Google Scholar
• Litovitz T L, Klein-Schwartz W, Rodgers G C Jr, Cobaugh D J, Youniss J, Omslaer J C, May M E, Woolf A D, Benson B E. 2001 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 2002; 20(5):391–452.
   PubMed Web of Science ®Google Scholar
• Litovitz T L, Klein-Schwartz W, White S, Cobaugh D J, Youniss J, Omslaer J C, Drab A, Benson B E. 2000 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 2001; 19(5):337–395.
   PubMed Web of Science ®Google Scholar
• Shaneyfelt T M, Mayo-Smith M F, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281(20):1900–1905.
   PubMed Web of Science ®Google Scholar
• In: Goldfrank L R, Flomenbaum N E, Lewin N A, Weisman R S, Howland M A, Hoffman R S, eds. Goldfrank's Toxicologic Emergencies. 6th ed. Stamford, CT: Appleton & Lange, 1998.
   Google Scholar
• In: Haddad L M, Shannon M W, Winchester J F, eds. Clinical Management of Poisoning and Drug Overdose. 3rd ed. Philadelphia: W.B. Saunders, 1998.
   Google Scholar
• In: Ellenhorn M J, ed. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore: Williams & Wilkins, 1997.
   Google Scholar
• Ford M D, Delaney K A, Ling L J, Erickson T. Clinical Toxicology. Philadelphia: W.B.Saunders, 2000.
   Google Scholar
• In: Olson K R, ed. Poisoning & Drug Overdose. 3rd ed..Stamford, CT: Appleton & Lange, 1999.
   Google Scholar
• In: Viccellio P, ed. Emergency Toxicology. 2nd ed. Philadelphia: Lippincott-Raven, 1998.
   Google Scholar
• Toll L L, Hurlbut K M. Poisindex System. Thomson Micromedex, Greenwood Village, CO. (, Edition Expired August 2002).
   Google Scholar
• Krenzelok E P, McGuigan M, Lheur P. Position statement: ipecac syrup. American academy of clinical toxicology European association of poisons centres and clinical toxicologists. J Toxicol Clin Toxicol 1997; 35(7):699–709.
   PubMedGoogle Scholar
• Woolf S H, Battista R N, Anderson G M, Logan A G, Wang E. Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian task force on the periodic health examination. J Clin Epidemiol 1990; 43(9):891–905.
   PubMed Web of Science ®Google Scholar
• Malcolm S B, Kuzemko J A. Ipecac syrup in acute poisoning in children. Practitioner 1969; 202(211):666–667.
   PubMedGoogle Scholar
• MacLean W C Jr. A comparison of ipecac syrup and apomorphine in the immediate treatment of ingestion of poisons. J Pediatr 1973; 82(1):121–124.
   PubMed Web of Science ®Google Scholar
• Veltri J C, Temple A R. Telephone management of poisonings using syrup of ipecac. Clin Toxicol 1976; 9(3):407–417.
   PubMed Web of Science ®Google Scholar
• Schofferman J A. A clinical comparison of syrup of ipecac and apomorphine use in adults. JACEP 1976; 5(1):22–25.
   PubMedGoogle Scholar
• Ilett K F, Gibb S M, Unsworth R W. Syrup of ipecacuanha as an emetic in adults. Med J Aust 1977; 2(3):91–93.
   PubMed Web of Science ®Google Scholar
• Krenzelok E P, Dean B S. Syrup of ipecac in children less than one year of age. J Toxicol Clin Toxicol 1985; 23(2–3):171–176.
   PubMed Web of Science ®Google Scholar
• Litovitz T L, Klein-Schwartz W, Oderda G M, Matyunas N J, Wiley S, Gorman R L. Ipecac administration in children younger than 1 year of age. Pediatrics 1985; 76(5):761–764.
   PubMed Web of Science ®Google Scholar
• Thoman M E, Verhulst H L. Ipecac syrup in antiemetic ingestion. JAMA 1966; 196(5):433–434.
   PubMed Web of Science ®Google Scholar
• Manoguerra A S, Krenzelok E P. Rapid emesis from high-dose ipecac syrup in adults and children intoxicated with antiemetics or other drugs. Am J Hosp Pharm 1978; 35(11):1360–1362.
   PubMedGoogle Scholar
• Neuvonen P J, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol 1983; 24(4):557–562.
   PubMed Web of Science ®Google Scholar
• Neuvonen P J, Olkkola K T. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. J Toxicol Clin Toxicol 1984; 22(2):103–114.
   PubMed Web of Science ®Google Scholar
• Auerbach P S, Osterloh J, Braun O, Hu P, Geehr E C, Kizer K W, McKinney H. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann Emerg Med 1986; 15(6):692–698.
   PubMed Web of Science ®Google Scholar
• Young W F Jr, Bivins H G. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis. Ann Emerg Med 1993; 22(9):1423–1427.
   PubMed Web of Science ®Google Scholar
• Saincher A, Sitar D S, Tenenbein M. Efficacy of ipecac during the first hour after drug ingestion in human volunteers. J Toxicol Clin Toxicol 1997; 35(6):609–615.
   PubMed Web of Science ®Google Scholar
• Vasquez T E, Evans D G, Ashburn W L. Efficacy of syrup of ipecac-induced emesis for emptying gastric contents. Clin Nucl Med 1988; 13(9):638–639.
   PubMed Web of Science ®Google Scholar
• Krenzelok E P, Dean B S. Effectiveness of 15-Ml versus 30-Ml doses of syrup of ipecac in children. Clin Pharm 1987; 6(9):715–717.
   PubMedGoogle Scholar
• Garrison J, Shepherd G, Huddleston W L, Watson W A. Evaluation of the time frame for home ipecac syrup use when not kept in the home. J Toxicol Clin Toxicol 2003; 41(3):217–221.
   PubMed Web of Science ®Google Scholar
• Abdallah A H, Tye A. A comparison of the efficacy of emetic drugs and stomach lavage. Am J Dis Child 1967; 113(5):571–575.
   PubMedGoogle Scholar
• Teshima D, Suzuki A, Otsubo K, Higuchi S, Aoyama T, Shimozono Y, Saita M, Noda K. Efficacy of emetic and united state pharmacopoeia ipecac syrup in prevention of drug absorption. Chem. Pharm. Bull. (Tokyo) 1990; 38(8):2242–2245.
   PubMed Web of Science ®Google Scholar
• Tandberg D, Diven B G, McLeod J W. Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults. Am J Emerg Med 1986; 4(3):205–209.
   PubMed Web of Science ®Google Scholar
• Cordonnier J, Van den Heede M, Heyndrickx A, Wennig R. Disposition of tilidine in a fatal poisoning in man. J Anal Toxicol 1987; 11(3):105–109.
   PubMed Web of Science ®Google Scholar
• Tenenbein M, Cohen S, Sitar D S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med 1987; 16(8):838–841.
   PubMed Web of Science ®Google Scholar
• McNamara R M, Aaron C K, Gemborys M, Davidheiser S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med 1989; 18(9):934–938.
   PubMed Web of Science ®Google Scholar
• Minton N A, Glucksman E, Henry J A. Prevention of drug absorption in simulated theophylline overdose. Human Exp Toxicol 1995; 14(2):170–174.
   PubMed Web of Science ®Google Scholar
• Corby D G, Decker W J, Moran M J, Payne C E. Clinical comparison of pharmacologic emetics in children. Pediatrics 1968; 42(2):361–364.
   PubMed Web of Science ®Google Scholar
• Saetta J P, Quinton D N. Residual gastric content after gastric lavage and ipecacuanha-induced emesis in self-poisoned patients: an endoscopic study. J R Soc Med 1991; 84(1):35–38.
   PubMed Web of Science ®Google Scholar
• Amitai Y, Mitchell A A, McGuigan M A, Lovejoy F H Jr. Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children. Pediatrics 1987; 80(3):364–367.
   PubMed Web of Science ®Google Scholar
• Underhill T J, Greene M K, Dove A F. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990; 7(3):148–154.
   PubMedGoogle Scholar
• Bond G R, Requa R K, Krenzelok E P, Normann S A, Tendler J D, Morris C L, McCoy D J, Thompson M W, McCarthy T, Roblez J, Taylor C, Dolan M A, Curry S C. Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann Emerg Med 1993; 22(9):1403–1407.
   PubMed Web of Science ®Google Scholar
• Kulig K, Bar-Or D, Cantrill S V, Rosen P, Rumack B H. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14(6):562–567.
   PubMed Web of Science ®Google Scholar
• Albertson T E, Derlet R W, Foulke G E, Minguillon M C, Tharratt S R. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med 1989; 18(1):56–59.
   PubMed Web of Science ®Google Scholar
• Kornberg A E, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991; 20(6):648–651.
   PubMed Web of Science ®Google Scholar
• Bond G R. Home use of syrup of ipecac is associated with a reduction in pediatric emergency department visits. Ann Emerg Med 1995; 25(3):338–343.
   PubMed Web of Science ®Google Scholar
• Manno B R, Manno J E. Toxicology of ipecac: a review. Clin Toxicol 1977; 10(2):221–242.
   PubMed Web of Science ®Google Scholar
• Wax P M, Cobaugh D J, Lawrence R A. Should home ipecac-induced emesis be routinely recommended in the management of toxic berry ingestions? Vet Hum Toxicol 1999; 41(6):394–397.
   PubMedGoogle Scholar
• Czajka P A, Russell S L. Nonemetic effects of ipecac syrup. Pediatrics 1985; 75(6):1101–1104.
   PubMed Web of Science ®Google Scholar
• Chafee-Bahamon C, Lacouture P G, Lovejoy F H Jr. Risk assessment of ipecac in the home. Pediatrics 1985; 75(6):1105–1109. , 1.
   PubMed Web of Science ®Google Scholar
• Wrenn K, Rodewald L, Dockstader L. Potential misuse of ipecac. Ann Emerg Med 1993; 22(9):1408–1412.
   PubMed Web of Science ®Google Scholar
• Tandberg D, Liechty E J, Fishbein D. Mallory-weiss syndrome: an unusual complication of ipecac-induced emesis. Ann Emerg Med 1981; 10(10):521–523.
   PubMed Web of Science ®Google Scholar
• Wolowodiuk O J, McMicken D B, O'Brien P. Pneumomediastinum and retropneumoperitoneum: an unusual complication of syrup-of-ipecac-induced emesis. Ann Emerg Med 1984; 13(12):1148–1151.
   PubMed Web of Science ®Google Scholar
• Knight K M, Doucet H J. Gastric rupture and death caused by ipecac syrup. South Med J 1987; 80(6):786–787.
   PubMed Web of Science ®Google Scholar
• Robertson W O. Syrup of ipecac associated fatality: a case report. Vet Hum Toxicol 1979; 21(2):87–89.
   PubMedGoogle Scholar
• Klein-Schwartz W, Gorman R L, Oderda G M, Wedin G P, Saggar D. Ipecac use in the elderly: the unanswered question. Ann Emerg Med 1984; 13(12):1152–1154.
   PubMed Web of Science ®Google Scholar
• Adler A G, Walinsky P, Krall R A, Cho S Y. Death resulting from ipecac syrup poisoning. JAMA 1980; 243(19):1927–1928.
   PubMed Web of Science ®Google Scholar
• Robertson W O. Safety of ipecac syrup. JAMA 1980; 244(15):1675.
   PubMed Web of Science ®Google Scholar
• Brotman M C, Forbath N, Garfinkel P E, Humphrey J G. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can Med Assoc J 1981; 125(5):453–454.
   PubMed Web of Science ®Google Scholar
• Mateer J E, Farrell B J, Chou S S, Gutmann L. Reversible ipecac myopathy. Arch Neurol 1985; 42(2):188–190.
   PubMed Web of Science ®Google Scholar
• Bennett H S, Spiro A J, Pollack M A, Zucker P. Ipecac-induced myopathy simulating dermatomyositis. Neurology 1982; 32(1):91–94.
   PubMed Web of Science ®Google Scholar
• Friedman E J. Death from ipecac intoxication in a patient with anorexia nervosa. Am J Psychiatr 1984; 141(5):702–703.
   PubMed Web of Science ®Google Scholar
• Moldawsky R J. Myopathy and ipecac abuse in a bulimic patient. Psychosomatics 1985; 26(5):448–449.
   PubMed Web of Science ®Google Scholar
• Palmer E P, Guay A T. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 1985; 313(23):1457–1459.
   PubMed Web of Science ®Google Scholar
• Dawson J A, Yager J. A case of abuse of syrup of ipecac resulting in death. J Am Coll Health 1986; 34(6):280–282.
   PubMedGoogle Scholar
• Rosenberg N L, Ringel S P. Myopathy from surreptitious ipecac ingestion. West J Med 1986; 145(3):386–388.
   PubMedGoogle Scholar
• Schiff R J, Wurzel C L, Brunson S C, Kasloff I, Nussbaum M P, Frank S D. Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatrics 1986; 78(3):412–416.
   PubMed Web of Science ®Google Scholar
• Friedman A G, Seime R J, Roberts T, Fremouw W J. Ipecac abuse: a serious complication in bulimia. Gen Hosp Psych 1987; 9(3):225–228.
   PubMed Web of Science ®Google Scholar
• Halbig L, Gutmann L, Goebel H H, Brick J F, Schochet S. Ultrastructural pathology in emetine-induced myopathy. Acta Neuropathol (Berl) 1988; 75(6):577–582.
   PubMed Web of Science ®Google Scholar
• Kuntzer T, Bogousslavsky J, Deruaz J P, Janzer R, Regli F. Reversible emetine-induced myopathy with ecg abnormalities: a toxic myopathy. J Neurol 1989; 236(4):246–248.
   PubMed Web of Science ®Google Scholar
• Dresser L P, Massey E W, Johnson E E, Bossen E. Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry 1993; 56(5):560–562.
   PubMed Web of Science ®Google Scholar
• Thyagarajan D, Day B J, Wodak J, Gilligan B, Dennett X. Emetine myopathy in a patient with an eating disorder. Med J Aust 1993; 159(11–12):757–760.
   PubMed Web of Science ®Google Scholar
• Ho P C, Dweik R, Cohen M C. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin Cardiol 1998; 21(10):780–783.
   PubMed Web of Science ®Google Scholar
• Cooper C, Kilham H, Ryan M. Ipecac-a substance of abuse. Med J Aust 1998; 168(2):94–95.
   PubMed Web of Science ®Google Scholar
• McClung H J, Murray R, Braden N J, Fyda J, Myers R P, Gutches L. Intentional ipecac poisoning in children. Am J Dis Child 1988; 142(6):637–639.
   PubMedGoogle Scholar
• Berkner P, Kastner T, Skolnick L. Chronic ipecac poisoning in infancy: a case report. Pediatrics 1988; 82(3):384–386.
   PubMed Web of Science ®Google Scholar
• Sutphen J L, Saulsbury F T. Intentional ipecac poisoning: munchausen syndrome by proxy. Pediatrics 1988; 82(3 Pt 2):453–456.
   PubMed Web of Science ®Google Scholar
• Colletti R B, Wasserman R C. Recurrent infantile vomiting due to intentional ipecac poisoning. J Pediatr Gastroenterol Nutr 1989; 8(3):394–396.
   PubMed Web of Science ®Google Scholar
• Day L, Kelly C, Reed G, Andersen J M, Keljo J M. Fatal cardiomyopathy: suspected child abuse by chronic ipecac administration. Vet Hum Toxicol 1989; 31(3):255–257.
   PubMedGoogle Scholar
• Santangelo W C, Richey J E, Rivera L, Fordtran J S. Surreptitious ipecac administration simulating intestinal pseudo-obstruction. Ann Intern Med 1989; 110(12):1031–1032.
   PubMed Web of Science ®Google Scholar
• Johnson J E, Carpenter B L, Benton J, Cross R, Eaton L A Jr, Rhoads J M. Hemorrhagic colitis and pseudomelanosis coli in ipecac ingestion by proxy. J Pediatr Gastroenterol Nutr 1991; 12(4):501–506.
   PubMed Web of Science ®Google Scholar
• Goebel J, Gremse D A, Artman M. Cardiomyopathy from ipecac administration in munchausen syndrome by proxy. Pediatrics 1993; 92(4):601–603.
   PubMed Web of Science ®Google Scholar
• Schneider D J, Perez A, Knilamus T E, Daniels S R, Bove K E, Bonnell H. Clinical and pathologic aspects of cardiomyopathy from ipecac administration in munchausen's syndrome by proxy. Pediatrics 1996; 97(6 Pt 1):902–906.
   PubMed Web of Science ®Google Scholar